Periodic update on transaction details related to Philips’ share repurchases

July 11, 2016

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today reported the transaction details related to the repurchases of its own common shares made in the period from July 4, 2016 up to and including July 7, 2016.


These repurchases were made under the EUR 1.5 billion share repurchase program for capital reduction purposes and the repurchase program to cover long term incentive and employee share purchase plans. Further details can be found in the table below and via this link.

Total number of repurchased shares
Weighted average purchased price (EUR)
July 4, 2016
July 5, 2016
July 6, 2016
July 7, 2016

For further information, please contact:

Steve Klink

Philips Group Communications

Tel.: +31 6 10888824


Leandro Mazzoni

Philips Investor Relations

Tel.: +31 20 5977055


About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Headquartered in the Netherlands, Philips’ health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 69,000 employees with sales and services in more than 100 countries. News about Philips can be found at